Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Ferric Carboxymaltose
90%
Iron Deficiency
84%
Acute Heart Failure
63%
Prognosis
33%
Heart Muscle Fibrosis
30%
Randomized Controlled Trial
30%
Ferritin
15%
Carcinogenicity
9%
Tissue Inhibitor of Metalloproteinase 4
9%
Gelatinase B
6%
Medicine and Dentistry
Heart Arrest
60%
Resuscitation
60%
Hospital
42%
Patient
36%
Inpatient
30%
Noradrenalin
30%
Retrospective Cohort Study
30%
Central Venous Catheter
15%
Intensive Care
11%
Extravasation
11%
Septic Shock
7%
Male
6%
Physician
6%
Overall Survival
6%
Observational Study
6%
Nervous System Physiology
6%
Age
6%
Smoking
5%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
30%
Classification
30%
Protein
18%
Metalloprotease Inhibitor
12%
Growth Differentiation Factor
9%
Volume
6%
MMP9
6%
Galectin-3
6%
Survival
5%
